Kyto Biopharma, Inc. Announces Management Changes
Corporation. Simon P. Westbrook has been appointed Chief Financial Officer of the Corporation. Peter Prendergast has resigned as Director of the Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+6.16% | 78.2B | |
+0.54% | 63B | |
+2.24% | 44.35B | |
-1.13% | 37.05B | |
+7.03% | 35.88B | |
-23.44% | 11.84B | |
+15.13% | 10.19B | |
-25.94% | 8.22B | |
+15.54% | 7.51B |